Under construction – not a live service
Sign in

NCT07921342Not yet recruiting

An Individuation Intervention to Reduce Socioeconomic Disparities in Chronic Kidney Disease Care

Source: ClinicalTrials.gov · Last updated 6 Nov 2026

Next steps

Brief summary (registry, in English)

The goal of this clinical trial is to test whether an individuation intervention can improve the quality of chronic kidney disease (CKD) care for patients with low socioeconomic status (SES) and to understand the mechanisms through which the intervention may improve care delivery and clinical outcomes. The study will involve nephrologists and their patients with CKD, with a focus on reducing healthcare disparities associated with low SES. Researchers will compare nephrologists who receive the individuation intervention with those in the control group to determine whether encouraging physicians to better understand their patients as unique individuals, rather than relying on assumptions associated with socioeconomic status, improves the quality of CKD care for patients with low SES.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
216 (estimated)
First submitted
2 Nov 2026
Start date
Jan 2027
Primary completion date
Jan 2028
Lead sponsor
Brigham and Women's Hospital
NCT number
NCT07921342

What you commit to

  • Study type: Interventional
  • Planned participants: 216
  • From Jan 2027 to the primary completion date, Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients who are incarcerated, pregnant or unable to consent
  • Patients from our searches who have opted out of research

Who the study is looking for

  • Nephrologists of any sex, race and ethnicity
  • >18 years of age
  • >=1 clinic at an MGB-affiliated clinic (BWH main campus, 850 Boylston, Foxborough, MGH main campus, 165 Cambridge Street, MGH West Waltham) where they care for patients that have chronic kidney disease (CKD)
    • For Patients:
  • Patients of any sex, race and ethnicity of the participating providers who are able to provide consent
  • English-speaking
  • >=18 years old
  • Insured by Medicaid/Mass Health (as a proxy for low socioeconomic status) or dually insured by Medicaid/Medicare
  • Have a diagnosis of CKD or a referral to nephrology for evaluation of CKD
  • Have been seen <=3 times in the past year by the nephrologist

Criteria the registry did not label

  • For Providers:

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Mass General BrighamSomervilleUnited StatesUnknown status

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.